Financial Strategies Acquisition Corp. (Nasdaq: FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences").
Financial Strategies Acquisition Corp. (NASDAQ: FXCO, the "Company"), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from February 14, 2023 to March 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to pro
Every investor in Financial Strategies Acquisition Corp. ( NASDAQ:FXCO ) should be aware of the most powerful...